Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,321 to 1,340 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ALOX12: A Novel Insight in Bevacizumab Response, Immunotherapy Effect, and Prognosis of Colorectal Cancer. | Front Immunol | 2022 | 35833141 | PubTator, text mining | PubMed |
| Detection and Quantification of Immunoregulatory miRNAs in Human Milk and Infant Milk Formula. | BioTech (Basel) | 2022 | 35822784 | PubTator, text mining | PubMed |
| Facts and Hopes for Immunotherapy in Renal Cell Carcinoma. | Clin Cancer Res | 2022 | 35819272 | PubTator, text mining | PubMed |
| Leukemic Stem Cell: A Mini-Review on Clinical Perspectives. | Front Oncol | 2022 | 35814466 | PubTator, text mining | PubMed |
| Chimeric Antigen Receptor T-Cells: An Overview of Concepts, Applications, Limitations, and Proposed Solutions. | Front Bioeng Biotechnol | 2022 | 35814023 | PubTator, text mining | PubMed |
| Over-Expression of GUSB Leads to Primary Resistance of Anti-PD1 Therapy in Hepatocellular Carcinoma. | Front Immunol | 2022 | 35812439 | PubTator, text mining | PubMed |
| Decoding the Immune Microenvironment of Clear Cell Renal Cell Carcinoma by Single-Cell Profiling to Aid Immunotherapy. | Front Immunol | 2022 | 35812372 | PubTator, text mining | PubMed |
| The trichloroethylene metabolite S-(1,2-dichlorovinyl)-l-cysteine inhibits lipopolysaccharide-induced inflammation transcriptomic pathways and cytokine secretion in a macrophage cell model. | Toxicol In Vitro | 2022 | 35811015 | PubTator, text mining | PubMed |
| Tumor Microenvironment and Immunotherapy-Based Approaches in Mantle Cell Lymphoma. | Cancers (Basel) | 2022 | 35804999 | PubTator, text mining | PubMed |
| The Role of microRNAs in Multidrug Resistance of Glioblastoma. | Cancers (Basel) | 2022 | 35804989 | PubTator, text mining | PubMed |
| Patient-derived renal cell carcinoma organoids for personalized cancer therapy. | Clin Transl Med | 2022 | 35802820 | PubTator, text mining | PubMed |
| Trial watch: Dendritic cell (DC)-based immunotherapy for cancer. | Oncoimmunology | 2022 | 35800158 | PubTator, text mining | PubMed |
| Downregulation of PTCD1 in Bladder Urothelial Carcinoma Predicts Poor Prognosis and Levels of Immune Infiltration. | J Oncol | 2022 | 35799606 | PubTator, text mining | PubMed |
| A structural homology approach to identify potential cross-reactive antibody responses following SARS-CoV-2 infection. | Sci Rep | 2022 | 35794133 | PubTator, text mining | PubMed |
| The Robust Tumoricidal Effects of Combined BET/HDAC Inhibition in Cutaneous T-Cell Lymphoma Can Be Reproduced by ΔNp73 Depletion. | J Invest Dermatol | 2022 | 35787399 | PubTator, text mining | PubMed |
| Glioblastoma: Current Status, Emerging Targets, and Recent Advances. | J Med Chem | 2022 | 35786935 | PubTator, text mining | PubMed |
| Identification of New Antibodies Targeting Malignant Plasma Cells for Immunotherapy by Next-Generation Sequencing-Assisted Phage Display. | Front Immunol | 2022 | 35784366 | PubTator, text mining | PubMed |
| Necroptosis-Related Genes Associated With Immune Activity and Prognosis of Colorectal Cancer. | Front Genet | 2022 | 35783272 | PubTator, text mining | PubMed |
| Glycoengineered anti-CD39 promotes anticancer responses by depleting suppressive cells and inhibiting angiogenesis in tumor models. | J Clin Invest | 2022 | 35775486 | PubTator, text mining | PubMed |
| Epigenetic and Transcriptomic Regulation Landscape in HPV+ Cancers: Biological and Clinical Implications. | Front Genet | 2022 | 35774512 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=67